Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

North America Biobanking Market Outlook

North America biobanking market size was valued at USD 1.1 billion in 2023, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2024-2032, with the values likely to rise from USD 1.2 billion in 2024 to USD 2 billion by 2032.

Key Takeaways

  • According to the Centers for Disease Control and Prevention, 6 out of 10 Americans are affected by at least one chronic disease.
  • In December 2023, a team of researchers developed a suite of computational tools that can reconstruct a three-dimensional picture of the brain from brain biobanks, which can help advance the understanding of neurodegenerative diseases.
  • In December 2023, New York-based Wilmot Cancer Institute received a grant worth USD 339,850 from Empire State Development (New York State funds).

North America Biobanking Market Analysis

Biobank is a type of biorepository containing large collections of biological materials (usually human). The large-scale biomedical database acts as a research resource to facilitate new scientific discoveries. Biological samples in biobanks can act as a vital tool for medical research and accelerate the development of new and innovative treatments.

North America biobanking market growth is driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, in the region. According to the Centers for Disease Control and Prevention, 6 out of 10 Americans are affected by at least one chronic disease. Moreover, chronic diseases not only rank as the leading causes of death and disability in America but are also a major driver of healthcare costs. Biobanks help in studying the genetic and environmental factors resulting in chronic diseases. Thus, with the growing prevalence of chronic diseases, the demand for biological samples in biomedical research is expected to rise, which will boost the market growth.

Technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks are expected to boost the North America biobanking market demand in the forecast period. In December 2023, a study primarily funded by the National Institute of Aging (a division of the United States National Institutes of Health) revealed the development of a suite of free computational tools that can analyze brain dissection photographs from brain biobanks and reconstruct a three-dimensional picture of the brain, which can help to understand neurodegenerative diseases and find their potential treatments. Thus, data from biobanks is increasingly used to advance the understanding of various brain disorders, which are anticipated to propel the market demand.

North America biobanking market share is likely to be positively impacted by increased fundings from government organizations to improve biobanking infrastructure and support research initiatives. In December 2023, New York-based Wilmot Cancer Institute (leader in cancer care and research) received a grant worth USD 339k from Empire State Development (New York State funds). The funding will help in renovations and the establishment of new technology for the institute’s Biobank Shared Resource. Such investments will support biobank upgrades and are likely to augment market size in the region.

North America Biobanking Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup Categories
Equipment Cryogenic Storage Systems, Alarm Monitoring Systems, Others
Media Optimized Media, Non-Optimized Media, Others
Services Human Tissue Biobanking, Stem Cell Biobanking, Cord Banking, DNA/RNA Biobanking, Others
Biospecimen Type Human Tissues, Human Organs, Stem Cells, Others
Application Drug Discovery, Disease Research, Others
End User Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others
Countries United States of America, Canada

North America Biobanking Market: Competitor Landscape

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Atlanta Biologicals Inc. (Bio-Techne Corporation)
  • Becton, Dickinson and Company
  • BioLifeSolution Inc.
  • Chart Industries Inc.
  • Hamilton Company
  • Qiagen NV
  • Sigma-Aldrich Inc. (Merck KGaA)
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • VWR International LLC

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Equipment
  • Media
  • Services
  • Biospecimen Type
  • Application
  • End User 
  • Region
Breakup by Equipment
  • Cryogenic Storage Systems
  • Alarm Monitoring Systems
  • Others
Breakup by Media
  • Optimized Media
  • Non-Optimized Media
  • Others 
Breakup by Services
  • Human Tissue Biobanking
  • Stem Cell Biobanking
  • Cord Banking
  • DNA/RNA Biobanking
  • Others
Breakup by Biospecimen Type
  • Human Tissues
  • Human Organs
  • Stem Cells
  • Others
Breakup by Application
  • Drug Discovery
  • Disease Research
  • Others
Breakup by End User 
  • Hospitals 
  • Cosmetology Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • United States of America
  • Canada
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Atlanta Biologicals Inc. (Bio-Techne Corporation)
  • Becton, Dickinson and Company
  • BioLifeSolution Inc.
  • Chart Industries Inc.
  • Hamilton Company
  • Qiagen NV
  • Sigma-Aldrich Inc. (Merck KGaA)
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • VWR International LLC

North America Biobanking Market Report Snapshots

North America Biobanking Market Size

North America Biobanking Market Analysis

North America Biobanking Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 1.1 billion in 2023 driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region.

The market is anticipated to grow at a CAGR of 6.31% during the forecast period of 2024-2032, likely to reach a market value of USD 2 billion by 2032. 

The growing demand for precision medicine and the rising funding from the government are fuelling the demand for the market.

One of the significant trends in the market is technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks. In December 2023, researchers developed a suite of computational tools that can reconstruct a three-dimensional picture of the brain from brain biobanks, which can help advance the understanding of neurodegenerative diseases.

Based on the equipment, the market is segmented into cryogenic storage systems, and alarm monitoring systems, among others.

Services available in the market include human tissue biobanking, stem cell biobanking, cord banking, and DNA/RNA biobanking, among others. 

By biospecimen type, the market is divided into human tissues, human organs, and stem cells, among others.

The market breakup by media includes optimized media and non-optimized media, among others.

End users of the market are hospitals, cosmetology clinics, and ambulatory surgical centers, among others.

Major application areas of biobanking include drug discovery and disease research, among others.

The market segmentation by countries includes the United States of America and Canada.   

The key players in the market are Atlanta Biologicals Inc. (Bio-Techne Corporation), Becton, Dickinson and Company, BioLifeSolution Inc., Chart Industries Inc., Hamilton Company, Qiagen NV, Sigma-Aldrich Inc. (Merck KGaA), STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and VWR International LLC. 

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,399

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 5,299

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 6,299

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124